COVID-19: impact of vaccination in myeloma patients

por Hoornaert, E., Dachy, F., Hansenne, A., Bailly, S., van Maanen, A., Gruson, D., Vekemans, M-C.
Publicado 2022

P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.

por Dachy, F., Furst, S., Calmels, B., Pagliardini, T., Harbi, S., Bouchacourt, B., Calleja, A., Lemarie, C., Collignon, A., Morel, G., Legrand, F., Bekrieva, E., Granata, A., Weiller, P. J., Chabannon, C., Schiano de Collela, J. M., Vey, N., Blaise, D., Devillier, R.
Publicado 2022

P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WHO UNDERWENT PERIPHERAL BLOOD HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OR HIGH RI...

por Harbi, S., Brac de la perriere, L., Garciaz, S., Pagliardini, T., Calmels, B., Cecile, M., Hicheri, Y., Bouchacourt, B., Calleja, A., Dachy, F., Fürst, S., Lemarie, C., Braticevic, C., Morel, G., Legrand, F., Bekrieva, E., Granata, A., Weiller, P. J., Chabannon, C., Vey, N., Blaise, D., Devillier, R.
Publicado 2022